Saturday, 17 October 2026European Markets

OREGE Stock 12.36% Up Before The Weekend

Loading stream...

(vianews) - the market ended the session with orege (orege.pa) jumping 12.36% to €0.60 on friday, following the last session's upward trend. cac 40 rose 0.06% to €7,374.54, after five consecutive sessions in a row of gains, on what was a somewhat bullish trend exchanging session today.

orege's last close was €0.53, 34.88% below its 52-week high of €0.82.

about orege

orege société anonyme designs, develops, operates, manufactures, and markets municipal and industrial sludge, and effluents treatment solutions in france, the united states, japan, germany, and the united kingdom. the company offers slg solution for conditioning, treating, and recovering municipal and industrial sludge; slg-f, a combination of slg conditioning solution; and flosep for sludge separation and thickening tool. it also provides after-sales, installation and commissioning, operator training, warranty extensions, maintenance, and process line optimization services. the company was incorporated in 2005 and is headquartered in voisins-le-bretonneux, france. orege société anonyme is a subsidiary of eren groupe sa.

earnings per share

as for profitability, orege has a trailing twelve months eps of €-0.14.

stock price classification

according to the stochastic oscillator, a useful indicator of overbought and oversold conditions, orege's stock is considered to be oversold (<=20).

sales growth

orege's sales growth for the current quarter is 73%.

volatility

orege's last week, last month's, and last quarter's current intraday variation average was a positive 7.01%, a negative 0.58%, and a positive 4.52%.

orege's highest amplitude of average volatility was 9.94% (last week), 6.32% (last month), and 4.52% (last quarter).

more news about orege (orege.pa).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Autumn 2026 Governance Reshuffle: CEO Successions, Activist Settlements and Corporate Separations
Across sectors, boards are replacing or rotating leadership (Bausch + Lomb's abrupt CEO exit, Keyser's move to advisor, Deputy CEO promotions, Brown-Forman and BellRing successions). At the same time, activist pressure is being settled through cooperation agreements and board seats (Stride/Fivespan, Al Shams) and through structural separations (National Fuel's IUG spin-out, NGEx). The common thread is boards using governance levers such as new committees, advisory seats and planned succession to reset capital allocation and strategy. Public messaging stresses continuity and partnership, but the number of interim appointments and activist-driven changes points to underlying pressure.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,384 source documents archived
Query this data → isubstrate.com